Lipid metabolism in interstitial lung diseases: serum amyloid A a new potential biomarker in idiopathic pulmonary fibrosis

被引：0
|
作者：
Vietri, Lucia [1 ]
D'Alessandro, Miriana [2 ]
Bergantini, Laura [2 ]
Cameli, Paolo [2 ]
Bargagli, Elena [2 ]
机构：
[1] Univ Ferrara, Ferrara, Italy
[2] Univ Siena, Siena, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA1142
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] ARE THE GAINS FROM PULMONARY REHABILITATION THE SAME IN IDIOPATHIC PULMONARY FIBROSIS AND OTHER INTERSTITIAL LUNG DISEASES?
    Ozmen, Ipek
    Yildirim, Elif
    Karaki, Meral
    Ozturk, Murat
    Aydin, Ruya
    Sahal, Emre
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2024, 41 (03)
  • [12] Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases
    d'Alessandro, Miriana
    De Vita, Elda
    Bergantini, Laura
    Mazzei, Maria Antonietta
    di Valvasone, Simona
    Bonizzoli, Manuela
    Peris, Adriano
    Sestini, Piersante
    Bargagli, Elena
    Bennett, David
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2020, 282
  • [13] The application of metabolomics toward idiopathic pulmonary fibrosis and potential metabolomic value of diverse samples in interstitial lung diseases
    Liu, Mingtao
    Cheng, Zhangkai J.
    Xue, Mingshan
    Lin, Runpei
    Zhang, Teng
    Sun, Baoqing
    PRECISION MEDICAL SCIENCES, 2023, 12 (03): : 134 - 143
  • [14] The difference of lung mechanics and chest kinematics in pulmonary rehabilitation of interstitial lung diseases versus idiopathic pulmonary fibrosis
    Kerti, Maria
    Bayer, Beatrix
    Kelemen, Krisztina
    Varga, Janos Tamas
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [15] Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
    Faverio, Paola
    Stainer, Anna
    Conti, Sara
    Madotto, Fabiana
    De Giacomi, Federica
    Della Zoppa, Matteo
    Vancheri, Ada
    Pellegrino, Maria Rosaria
    Tonelli, Roberto
    Cerri, Stefania
    Clini, Enrico M.
    Mantovani, Lorenzo Giovanni
    Pesci, Alberto
    Luppi, Fabrizio
    DIAGNOSTICS, 2021, 11 (09)
  • [16] Is pirfenidone ready for use in non-idiopathic pulmonary fibrosis interstitial lung diseases
    Dhooria, Sahajal
    Agarwal, Ritesh
    Gupta, Dheeraj
    LUNG INDIA, 2015, 32 (01) : 4 - +
  • [17] Interstitial lung abnormalities with a diagnosis of idiopathic pulmonary fibrosis
    Bando, Tomohiro
    Takei, Reoto
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Matsuda, Toshiaki
    Kataoka, Kensuke
    Kimura, Tomoki
    Johkoh, Takeshi
    Fukuoka, Junya
    Kondoh, Yasuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [18] Comprehensive biomarker analysis of patients with idiopathic pulmonary fibrosis and interstitial lung disease with healthy individuals
    Balci, A.
    Duz, M. E.
    Vurmaz, A.
    cilekar, S.
    Kaya, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (12) : 5468 - 5479
  • [19] Clinical analysis of autoimmune diseases associated with interstitial lung diseases initially presented with idiopathic pulmonary fibrosis
    陈茹萱
    ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (04) : 222 - 223
  • [20] Serum amyloid A: A potential biomarker of lung disorders
    Vietri, Lucia
    Fui, Annalisa
    Bergantini, Laura
    d'Alessandro, Miriana
    Cameli, Paolo
    Sestini, Piersante
    Rottoli, Paola
    Bargagli, Elena
    RESPIRATORY INVESTIGATION, 2020, 58 (01) : 21 - 27
12345